BIGG

Resultados: 2

Migreeni esmane diagnostika ja farmakoteraapia täiskasvanutel
Primary diagnosis and pharmacotherapy of migraine in adults

A study conducted in Estonia from January 2016 to May 2017 among adults aged 20-64 in the city of Tartu and Tartu County found that the annual prevalence of primary headaches in Estonia is as follows: all headaches 41.0%, migraine 17.7%, tension-type headache 18.0%, trigeminal autonomic cephalalgias 0.4%...

European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention

J. Head. Pain; 20 (6), 2019
BACKGROUND AND AIM: Monoclonal antibodies acting on the calcitonin gene-related peptide or on its receptor are new drugs to prevent migraine. Four monoclonal antibodies have been developed: one targeting the calcitonin gene-related peptide receptor (erenumab) and three targeting the calcitonin gene-relat...